PMC:7597510 / 4428-5445 JSONTXT

{"project":"LitCovid_Glycan-Motif-Structure","denotations":[{"id":"T7","span":{"begin":34,"end":41},"obj":"https://glytoucan.org/Structures/Glycans/G15021LG"},{"id":"T8","span":{"begin":378,"end":381},"obj":"https://glytoucan.org/Structures/Glycans/G46613JI"},{"id":"T9","span":{"begin":378,"end":381},"obj":"https://glytoucan.org/Structures/Glycans/G48558GR"},{"id":"T10","span":{"begin":383,"end":386},"obj":"https://glytoucan.org/Structures/Glycans/G61168WC"},{"id":"T11","span":{"begin":383,"end":386},"obj":"https://glytoucan.org/Structures/Glycans/G79389NT"},{"id":"T12","span":{"begin":388,"end":392},"obj":"https://glytoucan.org/Structures/Glycans/G46677TE"},{"id":"T13","span":{"begin":388,"end":392},"obj":"https://glytoucan.org/Structures/Glycans/G69277LC"},{"id":"T14","span":{"begin":394,"end":398},"obj":"https://glytoucan.org/Structures/Glycans/G37184KW"},{"id":"T15","span":{"begin":394,"end":398},"obj":"https://glytoucan.org/Structures/Glycans/G97612UN"},{"id":"T16","span":{"begin":400,"end":403},"obj":"https://glytoucan.org/Structures/Glycans/G81928IQ"},{"id":"T17","span":{"begin":400,"end":403},"obj":"https://glytoucan.org/Structures/Glycans/G98544DH"},{"id":"T18","span":{"begin":405,"end":416},"obj":"https://glytoucan.org/Structures/Glycans/G92175CL"},{"id":"T19","span":{"begin":418,"end":422},"obj":"https://glytoucan.org/Structures/Glycans/G68110IF"},{"id":"T20","span":{"begin":418,"end":422},"obj":"https://glytoucan.org/Structures/Glycans/G93468NI"},{"id":"T21","span":{"begin":424,"end":428},"obj":"https://glytoucan.org/Structures/Glycans/G05952XV"},{"id":"T22","span":{"begin":424,"end":428},"obj":"https://glytoucan.org/Structures/Glycans/G40183QN"},{"id":"T23","span":{"begin":430,"end":434},"obj":"https://glytoucan.org/Structures/Glycans/G17077FL"},{"id":"T24","span":{"begin":430,"end":434},"obj":"https://glytoucan.org/Structures/Glycans/G18625KA"},{"id":"T25","span":{"begin":444,"end":454},"obj":"https://glytoucan.org/Structures/Glycans/G00407UJ"},{"id":"T26","span":{"begin":444,"end":454},"obj":"https://glytoucan.org/Structures/Glycans/G21856LC"}],"text":"Blood tests revealed normal blood glucose levels and no findings suggestive of collagen disease, thyroid disease or vitamin abnormalities. Cerebrospinal fluid (CSF) assessment at admission at approximately 3 weeks after onset revealed normal protein levels and cell counts. All tests for antiganglioside antibodies were negative. The ganglioside antigens used in the ELISA were GM1, GM2, GD1a, GD1b, GD3, GalNAc-GD1a, GT1a, GT1b, GQ1b and GA1 (asialo-GM1). Ganglioside complexes containing two of the above 10 antigens were also used as described in a previous study.15 CSF was not tested for SARS-CoV-2 PCR. On admission, the patient’s first electrophysiological examination was normal. However, the second examination performed 1 week later revealed decreases in compound muscle action potential (CMAP) amplitudes in the median, radial and tibial nerves compared with those obtained in the first examination (table 1). Since the patient had a history of asthma, we did not perform lumbar MRI using a contrast agent."}

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T22","span":{"begin":0,"end":5},"obj":"Body_part"},{"id":"T23","span":{"begin":28,"end":33},"obj":"Body_part"},{"id":"T24","span":{"begin":34,"end":41},"obj":"Body_part"},{"id":"T25","span":{"begin":79,"end":87},"obj":"Body_part"},{"id":"T26","span":{"begin":97,"end":104},"obj":"Body_part"},{"id":"T27","span":{"begin":139,"end":158},"obj":"Body_part"},{"id":"T28","span":{"begin":160,"end":163},"obj":"Body_part"},{"id":"T29","span":{"begin":242,"end":249},"obj":"Body_part"},{"id":"T30","span":{"begin":261,"end":265},"obj":"Body_part"},{"id":"T31","span":{"begin":334,"end":345},"obj":"Body_part"},{"id":"T32","span":{"begin":457,"end":468},"obj":"Body_part"},{"id":"T33","span":{"begin":570,"end":573},"obj":"Body_part"},{"id":"T34","span":{"begin":774,"end":780},"obj":"Body_part"},{"id":"T35","span":{"begin":842,"end":855},"obj":"Body_part"}],"attributes":[{"id":"A22","pred":"fma_id","subj":"T22","obj":"http://purl.org/sig/ont/fma/fma9670"},{"id":"A23","pred":"fma_id","subj":"T23","obj":"http://purl.org/sig/ont/fma/fma9670"},{"id":"A24","pred":"fma_id","subj":"T24","obj":"http://purl.org/sig/ont/fma/fma82743"},{"id":"A25","pred":"fma_id","subj":"T25","obj":"http://purl.org/sig/ont/fma/fma63891"},{"id":"A26","pred":"fma_id","subj":"T26","obj":"http://purl.org/sig/ont/fma/fma9603"},{"id":"A27","pred":"fma_id","subj":"T27","obj":"http://purl.org/sig/ont/fma/fma20935"},{"id":"A28","pred":"fma_id","subj":"T28","obj":"http://purl.org/sig/ont/fma/fma20935"},{"id":"A29","pred":"fma_id","subj":"T29","obj":"http://purl.org/sig/ont/fma/fma67257"},{"id":"A30","pred":"fma_id","subj":"T30","obj":"http://purl.org/sig/ont/fma/fma68646"},{"id":"A31","pred":"fma_id","subj":"T31","obj":"http://purl.org/sig/ont/fma/fma82816"},{"id":"A32","pred":"fma_id","subj":"T32","obj":"http://purl.org/sig/ont/fma/fma82816"},{"id":"A33","pred":"fma_id","subj":"T33","obj":"http://purl.org/sig/ont/fma/fma20935"},{"id":"A34","pred":"fma_id","subj":"T34","obj":"http://purl.org/sig/ont/fma/fma32558"},{"id":"A35","pred":"fma_id","subj":"T35","obj":"http://purl.org/sig/ont/fma/fma19035"}],"text":"Blood tests revealed normal blood glucose levels and no findings suggestive of collagen disease, thyroid disease or vitamin abnormalities. Cerebrospinal fluid (CSF) assessment at admission at approximately 3 weeks after onset revealed normal protein levels and cell counts. All tests for antiganglioside antibodies were negative. The ganglioside antigens used in the ELISA were GM1, GM2, GD1a, GD1b, GD3, GalNAc-GD1a, GT1a, GT1b, GQ1b and GA1 (asialo-GM1). Ganglioside complexes containing two of the above 10 antigens were also used as described in a previous study.15 CSF was not tested for SARS-CoV-2 PCR. On admission, the patient’s first electrophysiological examination was normal. However, the second examination performed 1 week later revealed decreases in compound muscle action potential (CMAP) amplitudes in the median, radial and tibial nerves compared with those obtained in the first examination (table 1). Since the patient had a history of asthma, we did not perform lumbar MRI using a contrast agent."}

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T7","span":{"begin":0,"end":5},"obj":"Body_part"},{"id":"T8","span":{"begin":28,"end":33},"obj":"Body_part"},{"id":"T9","span":{"begin":97,"end":104},"obj":"Body_part"},{"id":"T10","span":{"begin":139,"end":158},"obj":"Body_part"},{"id":"T11","span":{"begin":842,"end":855},"obj":"Body_part"}],"attributes":[{"id":"A7","pred":"uberon_id","subj":"T7","obj":"http://purl.obolibrary.org/obo/UBERON_0000178"},{"id":"A8","pred":"uberon_id","subj":"T8","obj":"http://purl.obolibrary.org/obo/UBERON_0000178"},{"id":"A9","pred":"uberon_id","subj":"T9","obj":"http://purl.obolibrary.org/obo/UBERON_0002046"},{"id":"A10","pred":"uberon_id","subj":"T10","obj":"http://purl.obolibrary.org/obo/UBERON_0001359"},{"id":"A11","pred":"uberon_id","subj":"T11","obj":"http://purl.obolibrary.org/obo/UBERON_0001323"}],"text":"Blood tests revealed normal blood glucose levels and no findings suggestive of collagen disease, thyroid disease or vitamin abnormalities. Cerebrospinal fluid (CSF) assessment at admission at approximately 3 weeks after onset revealed normal protein levels and cell counts. All tests for antiganglioside antibodies were negative. The ganglioside antigens used in the ELISA were GM1, GM2, GD1a, GD1b, GD3, GalNAc-GD1a, GT1a, GT1b, GQ1b and GA1 (asialo-GM1). Ganglioside complexes containing two of the above 10 antigens were also used as described in a previous study.15 CSF was not tested for SARS-CoV-2 PCR. On admission, the patient’s first electrophysiological examination was normal. However, the second examination performed 1 week later revealed decreases in compound muscle action potential (CMAP) amplitudes in the median, radial and tibial nerves compared with those obtained in the first examination (table 1). Since the patient had a history of asthma, we did not perform lumbar MRI using a contrast agent."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T59","span":{"begin":79,"end":95},"obj":"Disease"},{"id":"T60","span":{"begin":97,"end":112},"obj":"Disease"},{"id":"T61","span":{"begin":439,"end":442},"obj":"Disease"},{"id":"T62","span":{"begin":593,"end":601},"obj":"Disease"},{"id":"T63","span":{"begin":956,"end":962},"obj":"Disease"}],"attributes":[{"id":"A59","pred":"mondo_id","subj":"T59","obj":"http://purl.obolibrary.org/obo/MONDO_0005554"},{"id":"A60","pred":"mondo_id","subj":"T60","obj":"http://purl.obolibrary.org/obo/MONDO_0003240"},{"id":"A61","pred":"mondo_id","subj":"T61","obj":"http://purl.obolibrary.org/obo/MONDO_0009281"},{"id":"A62","pred":"mondo_id","subj":"T62","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A63","pred":"mondo_id","subj":"T63","obj":"http://purl.obolibrary.org/obo/MONDO_0004979"}],"text":"Blood tests revealed normal blood glucose levels and no findings suggestive of collagen disease, thyroid disease or vitamin abnormalities. Cerebrospinal fluid (CSF) assessment at admission at approximately 3 weeks after onset revealed normal protein levels and cell counts. All tests for antiganglioside antibodies were negative. The ganglioside antigens used in the ELISA were GM1, GM2, GD1a, GD1b, GD3, GalNAc-GD1a, GT1a, GT1b, GQ1b and GA1 (asialo-GM1). Ganglioside complexes containing two of the above 10 antigens were also used as described in a previous study.15 CSF was not tested for SARS-CoV-2 PCR. On admission, the patient’s first electrophysiological examination was normal. However, the second examination performed 1 week later revealed decreases in compound muscle action potential (CMAP) amplitudes in the median, radial and tibial nerves compared with those obtained in the first examination (table 1). Since the patient had a history of asthma, we did not perform lumbar MRI using a contrast agent."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T40","span":{"begin":0,"end":5},"obj":"http://purl.obolibrary.org/obo/UBERON_0000178"},{"id":"T41","span":{"begin":0,"end":5},"obj":"http://www.ebi.ac.uk/efo/EFO_0000296"},{"id":"T42","span":{"begin":6,"end":11},"obj":"http://purl.obolibrary.org/obo/UBERON_0000473"},{"id":"T43","span":{"begin":28,"end":33},"obj":"http://purl.obolibrary.org/obo/UBERON_0000178"},{"id":"T44","span":{"begin":28,"end":33},"obj":"http://www.ebi.ac.uk/efo/EFO_0000296"},{"id":"T45","span":{"begin":79,"end":87},"obj":"http://purl.obolibrary.org/obo/CHEBI_3815"},{"id":"T46","span":{"begin":261,"end":265},"obj":"http://purl.obolibrary.org/obo/GO_0005623"},{"id":"T47","span":{"begin":278,"end":283},"obj":"http://purl.obolibrary.org/obo/UBERON_0000473"},{"id":"T48","span":{"begin":383,"end":386},"obj":"http://purl.obolibrary.org/obo/CLO_0003535"},{"id":"T49","span":{"begin":550,"end":551},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T50","span":{"begin":582,"end":588},"obj":"http://purl.obolibrary.org/obo/UBERON_0000473"},{"id":"T51","span":{"begin":774,"end":780},"obj":"http://purl.obolibrary.org/obo/UBERON_0001630"},{"id":"T52","span":{"begin":774,"end":780},"obj":"http://purl.obolibrary.org/obo/UBERON_0005090"},{"id":"T53","span":{"begin":774,"end":780},"obj":"http://www.ebi.ac.uk/efo/EFO_0000801"},{"id":"T54","span":{"begin":774,"end":780},"obj":"http://www.ebi.ac.uk/efo/EFO_0001949"},{"id":"T55","span":{"begin":849,"end":855},"obj":"http://purl.obolibrary.org/obo/UBERON_0001021"},{"id":"T56","span":{"begin":943,"end":944},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T57","span":{"begin":1000,"end":1001},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"Blood tests revealed normal blood glucose levels and no findings suggestive of collagen disease, thyroid disease or vitamin abnormalities. Cerebrospinal fluid (CSF) assessment at admission at approximately 3 weeks after onset revealed normal protein levels and cell counts. All tests for antiganglioside antibodies were negative. The ganglioside antigens used in the ELISA were GM1, GM2, GD1a, GD1b, GD3, GalNAc-GD1a, GT1a, GT1b, GQ1b and GA1 (asialo-GM1). Ganglioside complexes containing two of the above 10 antigens were also used as described in a previous study.15 CSF was not tested for SARS-CoV-2 PCR. On admission, the patient’s first electrophysiological examination was normal. However, the second examination performed 1 week later revealed decreases in compound muscle action potential (CMAP) amplitudes in the median, radial and tibial nerves compared with those obtained in the first examination (table 1). Since the patient had a history of asthma, we did not perform lumbar MRI using a contrast agent."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T20","span":{"begin":34,"end":41},"obj":"Chemical"},{"id":"T22","span":{"begin":116,"end":123},"obj":"Chemical"},{"id":"T23","span":{"begin":242,"end":249},"obj":"Chemical"},{"id":"T24","span":{"begin":334,"end":345},"obj":"Chemical"},{"id":"T25","span":{"begin":346,"end":354},"obj":"Chemical"},{"id":"T26","span":{"begin":378,"end":381},"obj":"Chemical"},{"id":"T29","span":{"begin":383,"end":386},"obj":"Chemical"},{"id":"T33","span":{"begin":388,"end":392},"obj":"Chemical"},{"id":"T35","span":{"begin":394,"end":398},"obj":"Chemical"},{"id":"T36","span":{"begin":400,"end":403},"obj":"Chemical"},{"id":"T38","span":{"begin":405,"end":416},"obj":"Chemical"},{"id":"T39","span":{"begin":405,"end":411},"obj":"Chemical"},{"id":"T41","span":{"begin":412,"end":416},"obj":"Chemical"},{"id":"T43","span":{"begin":418,"end":422},"obj":"Chemical"},{"id":"T44","span":{"begin":424,"end":428},"obj":"Chemical"},{"id":"T45","span":{"begin":430,"end":434},"obj":"Chemical"},{"id":"T46","span":{"begin":439,"end":442},"obj":"Chemical"},{"id":"T48","span":{"begin":451,"end":454},"obj":"Chemical"},{"id":"T51","span":{"begin":457,"end":468},"obj":"Chemical"},{"id":"T52","span":{"begin":510,"end":518},"obj":"Chemical"}],"attributes":[{"id":"A20","pred":"chebi_id","subj":"T20","obj":"http://purl.obolibrary.org/obo/CHEBI_17234"},{"id":"A21","pred":"chebi_id","subj":"T20","obj":"http://purl.obolibrary.org/obo/CHEBI_4167"},{"id":"A22","pred":"chebi_id","subj":"T22","obj":"http://purl.obolibrary.org/obo/CHEBI_33229"},{"id":"A23","pred":"chebi_id","subj":"T23","obj":"http://purl.obolibrary.org/obo/CHEBI_36080"},{"id":"A24","pred":"chebi_id","subj":"T24","obj":"http://purl.obolibrary.org/obo/CHEBI_28892"},{"id":"A25","pred":"chebi_id","subj":"T25","obj":"http://purl.obolibrary.org/obo/CHEBI_59132"},{"id":"A26","pred":"chebi_id","subj":"T26","obj":"http://purl.obolibrary.org/obo/CHEBI_18216"},{"id":"A27","pred":"chebi_id","subj":"T26","obj":"http://purl.obolibrary.org/obo/CHEBI_61048"},{"id":"A28","pred":"chebi_id","subj":"T26","obj":"http://purl.obolibrary.org/obo/CHEBI_73110"},{"id":"A29","pred":"chebi_id","subj":"T29","obj":"http://purl.obolibrary.org/obo/CHEBI_141420"},{"id":"A30","pred":"chebi_id","subj":"T29","obj":"http://purl.obolibrary.org/obo/CHEBI_51013"},{"id":"A31","pred":"chebi_id","subj":"T29","obj":"http://purl.obolibrary.org/obo/CHEBI_60327"},{"id":"A32","pred":"chebi_id","subj":"T29","obj":"http://purl.obolibrary.org/obo/CHEBI_89635"},{"id":"A33","pred":"chebi_id","subj":"T33","obj":"http://purl.obolibrary.org/obo/CHEBI_18163"},{"id":"A34","pred":"chebi_id","subj":"T33","obj":"http://purl.obolibrary.org/obo/CHEBI_82607"},{"id":"A35","pred":"chebi_id","subj":"T35","obj":"http://purl.obolibrary.org/obo/CHEBI_28175"},{"id":"A36","pred":"chebi_id","subj":"T36","obj":"http://purl.obolibrary.org/obo/CHEBI_28424"},{"id":"A37","pred":"chebi_id","subj":"T36","obj":"http://purl.obolibrary.org/obo/CHEBI_89636"},{"id":"A38","pred":"chebi_id","subj":"T38","obj":"http://purl.obolibrary.org/obo/CHEBI_59228"},{"id":"A39","pred":"chebi_id","subj":"T39","obj":"http://purl.obolibrary.org/obo/CHEBI_28037"},{"id":"A40","pred":"chebi_id","subj":"T39","obj":"http://purl.obolibrary.org/obo/CHEBI_28800"},{"id":"A41","pred":"chebi_id","subj":"T41","obj":"http://purl.obolibrary.org/obo/CHEBI_18163"},{"id":"A42","pred":"chebi_id","subj":"T41","obj":"http://purl.obolibrary.org/obo/CHEBI_82607"},{"id":"A43","pred":"chebi_id","subj":"T43","obj":"http://purl.obolibrary.org/obo/CHEBI_27691"},{"id":"A44","pred":"chebi_id","subj":"T44","obj":"http://purl.obolibrary.org/obo/CHEBI_28058"},{"id":"A45","pred":"chebi_id","subj":"T45","obj":"http://purl.obolibrary.org/obo/CHEBI_27515"},{"id":"A46","pred":"chebi_id","subj":"T46","obj":"http://purl.obolibrary.org/obo/CHEBI_27717"},{"id":"A47","pred":"chebi_id","subj":"T46","obj":"http://purl.obolibrary.org/obo/CHEBI_27938"},{"id":"A48","pred":"chebi_id","subj":"T48","obj":"http://purl.obolibrary.org/obo/CHEBI_18216"},{"id":"A49","pred":"chebi_id","subj":"T48","obj":"http://purl.obolibrary.org/obo/CHEBI_61048"},{"id":"A50","pred":"chebi_id","subj":"T48","obj":"http://purl.obolibrary.org/obo/CHEBI_73110"},{"id":"A51","pred":"chebi_id","subj":"T51","obj":"http://purl.obolibrary.org/obo/CHEBI_28892"},{"id":"A52","pred":"chebi_id","subj":"T52","obj":"http://purl.obolibrary.org/obo/CHEBI_59132"}],"text":"Blood tests revealed normal blood glucose levels and no findings suggestive of collagen disease, thyroid disease or vitamin abnormalities. Cerebrospinal fluid (CSF) assessment at admission at approximately 3 weeks after onset revealed normal protein levels and cell counts. All tests for antiganglioside antibodies were negative. The ganglioside antigens used in the ELISA were GM1, GM2, GD1a, GD1b, GD3, GalNAc-GD1a, GT1a, GT1b, GQ1b and GA1 (asialo-GM1). Ganglioside complexes containing two of the above 10 antigens were also used as described in a previous study.15 CSF was not tested for SARS-CoV-2 PCR. On admission, the patient’s first electrophysiological examination was normal. However, the second examination performed 1 week later revealed decreases in compound muscle action potential (CMAP) amplitudes in the median, radial and tibial nerves compared with those obtained in the first examination (table 1). Since the patient had a history of asthma, we did not perform lumbar MRI using a contrast agent."}

{"project":"LitCovid-PubTator","denotations":[{"id":"127","span":{"begin":400,"end":403},"obj":"Gene"},{"id":"128","span":{"begin":593,"end":603},"obj":"Species"},{"id":"129","span":{"begin":627,"end":634},"obj":"Species"},{"id":"130","span":{"begin":931,"end":938},"obj":"Species"},{"id":"131","span":{"begin":34,"end":41},"obj":"Chemical"},{"id":"132","span":{"begin":334,"end":345},"obj":"Chemical"},{"id":"133","span":{"begin":457,"end":468},"obj":"Chemical"},{"id":"134","span":{"begin":79,"end":95},"obj":"Disease"},{"id":"135","span":{"begin":97,"end":112},"obj":"Disease"},{"id":"136","span":{"begin":116,"end":137},"obj":"Disease"},{"id":"137","span":{"begin":956,"end":962},"obj":"Disease"}],"attributes":[{"id":"A127","pred":"tao:has_database_id","subj":"127","obj":"Gene:117189"},{"id":"A128","pred":"tao:has_database_id","subj":"128","obj":"Tax:2697049"},{"id":"A129","pred":"tao:has_database_id","subj":"129","obj":"Tax:9606"},{"id":"A130","pred":"tao:has_database_id","subj":"130","obj":"Tax:9606"},{"id":"A131","pred":"tao:has_database_id","subj":"131","obj":"MESH:D005947"},{"id":"A132","pred":"tao:has_database_id","subj":"132","obj":"MESH:D005732"},{"id":"A133","pred":"tao:has_database_id","subj":"133","obj":"MESH:D005732"},{"id":"A134","pred":"tao:has_database_id","subj":"134","obj":"MESH:D003095"},{"id":"A135","pred":"tao:has_database_id","subj":"135","obj":"MESH:D013959"},{"id":"A136","pred":"tao:has_database_id","subj":"136","obj":"MESH:D014802"},{"id":"A137","pred":"tao:has_database_id","subj":"137","obj":"MESH:D001249"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Blood tests revealed normal blood glucose levels and no findings suggestive of collagen disease, thyroid disease or vitamin abnormalities. Cerebrospinal fluid (CSF) assessment at admission at approximately 3 weeks after onset revealed normal protein levels and cell counts. All tests for antiganglioside antibodies were negative. The ganglioside antigens used in the ELISA were GM1, GM2, GD1a, GD1b, GD3, GalNAc-GD1a, GT1a, GT1b, GQ1b and GA1 (asialo-GM1). Ganglioside complexes containing two of the above 10 antigens were also used as described in a previous study.15 CSF was not tested for SARS-CoV-2 PCR. On admission, the patient’s first electrophysiological examination was normal. However, the second examination performed 1 week later revealed decreases in compound muscle action potential (CMAP) amplitudes in the median, radial and tibial nerves compared with those obtained in the first examination (table 1). Since the patient had a history of asthma, we did not perform lumbar MRI using a contrast agent."}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T14","span":{"begin":97,"end":112},"obj":"Phenotype"},{"id":"T15","span":{"begin":956,"end":962},"obj":"Phenotype"}],"attributes":[{"id":"A14","pred":"hp_id","subj":"T14","obj":"http://purl.obolibrary.org/obo/HP_0000820"},{"id":"A15","pred":"hp_id","subj":"T15","obj":"http://purl.obolibrary.org/obo/HP_0002099"}],"text":"Blood tests revealed normal blood glucose levels and no findings suggestive of collagen disease, thyroid disease or vitamin abnormalities. Cerebrospinal fluid (CSF) assessment at admission at approximately 3 weeks after onset revealed normal protein levels and cell counts. All tests for antiganglioside antibodies were negative. The ganglioside antigens used in the ELISA were GM1, GM2, GD1a, GD1b, GD3, GalNAc-GD1a, GT1a, GT1b, GQ1b and GA1 (asialo-GM1). Ganglioside complexes containing two of the above 10 antigens were also used as described in a previous study.15 CSF was not tested for SARS-CoV-2 PCR. On admission, the patient’s first electrophysiological examination was normal. However, the second examination performed 1 week later revealed decreases in compound muscle action potential (CMAP) amplitudes in the median, radial and tibial nerves compared with those obtained in the first examination (table 1). Since the patient had a history of asthma, we did not perform lumbar MRI using a contrast agent."}

{"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T3","span":{"begin":781,"end":797},"obj":"http://purl.obolibrary.org/obo/GO_0001508"}],"text":"Blood tests revealed normal blood glucose levels and no findings suggestive of collagen disease, thyroid disease or vitamin abnormalities. Cerebrospinal fluid (CSF) assessment at admission at approximately 3 weeks after onset revealed normal protein levels and cell counts. All tests for antiganglioside antibodies were negative. The ganglioside antigens used in the ELISA were GM1, GM2, GD1a, GD1b, GD3, GalNAc-GD1a, GT1a, GT1b, GQ1b and GA1 (asialo-GM1). Ganglioside complexes containing two of the above 10 antigens were also used as described in a previous study.15 CSF was not tested for SARS-CoV-2 PCR. On admission, the patient’s first electrophysiological examination was normal. However, the second examination performed 1 week later revealed decreases in compound muscle action potential (CMAP) amplitudes in the median, radial and tibial nerves compared with those obtained in the first examination (table 1). Since the patient had a history of asthma, we did not perform lumbar MRI using a contrast agent."}

{"project":"LitCovid-sentences","denotations":[{"id":"T33","span":{"begin":0,"end":138},"obj":"Sentence"},{"id":"T34","span":{"begin":139,"end":273},"obj":"Sentence"},{"id":"T35","span":{"begin":274,"end":329},"obj":"Sentence"},{"id":"T36","span":{"begin":330,"end":456},"obj":"Sentence"},{"id":"T37","span":{"begin":457,"end":608},"obj":"Sentence"},{"id":"T38","span":{"begin":609,"end":687},"obj":"Sentence"},{"id":"T39","span":{"begin":688,"end":920},"obj":"Sentence"},{"id":"T40","span":{"begin":921,"end":1017},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Blood tests revealed normal blood glucose levels and no findings suggestive of collagen disease, thyroid disease or vitamin abnormalities. Cerebrospinal fluid (CSF) assessment at admission at approximately 3 weeks after onset revealed normal protein levels and cell counts. All tests for antiganglioside antibodies were negative. The ganglioside antigens used in the ELISA were GM1, GM2, GD1a, GD1b, GD3, GalNAc-GD1a, GT1a, GT1b, GQ1b and GA1 (asialo-GM1). Ganglioside complexes containing two of the above 10 antigens were also used as described in a previous study.15 CSF was not tested for SARS-CoV-2 PCR. On admission, the patient’s first electrophysiological examination was normal. However, the second examination performed 1 week later revealed decreases in compound muscle action potential (CMAP) amplitudes in the median, radial and tibial nerves compared with those obtained in the first examination (table 1). Since the patient had a history of asthma, we did not perform lumbar MRI using a contrast agent."}

{"project":"LitCovid-PD-GlycoEpitope","denotations":[{"id":"T6","span":{"begin":378,"end":381},"obj":"GlycoEpitope"},{"id":"T7","span":{"begin":388,"end":392},"obj":"GlycoEpitope"},{"id":"T8","span":{"begin":394,"end":398},"obj":"GlycoEpitope"},{"id":"T9","span":{"begin":405,"end":416},"obj":"GlycoEpitope"},{"id":"T10","span":{"begin":412,"end":416},"obj":"GlycoEpitope"},{"id":"T11","span":{"begin":418,"end":422},"obj":"GlycoEpitope"},{"id":"T12","span":{"begin":424,"end":428},"obj":"GlycoEpitope"},{"id":"T13","span":{"begin":430,"end":434},"obj":"GlycoEpitope"},{"id":"T14","span":{"begin":451,"end":454},"obj":"GlycoEpitope"}],"attributes":[{"id":"A6","pred":"glyco_epitope_db_id","subj":"T6","obj":"http://www.glycoepitope.jp/epitopes/EP0050"},{"id":"A7","pred":"glyco_epitope_db_id","subj":"T7","obj":"http://www.glycoepitope.jp/epitopes/EP0056"},{"id":"A8","pred":"glyco_epitope_db_id","subj":"T8","obj":"http://www.glycoepitope.jp/epitopes/EP0059"},{"id":"A9","pred":"glyco_epitope_db_id","subj":"T9","obj":"http://www.glycoepitope.jp/epitopes/EP0058"},{"id":"A10","pred":"glyco_epitope_db_id","subj":"T10","obj":"http://www.glycoepitope.jp/epitopes/EP0056"},{"id":"A11","pred":"glyco_epitope_db_id","subj":"T11","obj":"http://www.glycoepitope.jp/epitopes/EP0066"},{"id":"A12","pred":"glyco_epitope_db_id","subj":"T12","obj":"http://www.glycoepitope.jp/epitopes/EP0067"},{"id":"A13","pred":"glyco_epitope_db_id","subj":"T13","obj":"http://www.glycoepitope.jp/epitopes/EP0069"},{"id":"A14","pred":"glyco_epitope_db_id","subj":"T14","obj":"http://www.glycoepitope.jp/epitopes/EP0050"}],"text":"Blood tests revealed normal blood glucose levels and no findings suggestive of collagen disease, thyroid disease or vitamin abnormalities. Cerebrospinal fluid (CSF) assessment at admission at approximately 3 weeks after onset revealed normal protein levels and cell counts. All tests for antiganglioside antibodies were negative. The ganglioside antigens used in the ELISA were GM1, GM2, GD1a, GD1b, GD3, GalNAc-GD1a, GT1a, GT1b, GQ1b and GA1 (asialo-GM1). Ganglioside complexes containing two of the above 10 antigens were also used as described in a previous study.15 CSF was not tested for SARS-CoV-2 PCR. On admission, the patient’s first electrophysiological examination was normal. However, the second examination performed 1 week later revealed decreases in compound muscle action potential (CMAP) amplitudes in the median, radial and tibial nerves compared with those obtained in the first examination (table 1). Since the patient had a history of asthma, we did not perform lumbar MRI using a contrast agent."}